Bulgaria – Medical consumables – ДОСТАВКА НА МЕДИЦИНСКИ ИЗДЕЛИЯ, ПРЕВЪРЗОЧНИ МАТЕРИАЛИ и ПАМПЕРСИ за УМБАЛИПБ ''ПРОФ. ИВАН КИРОВ"
ted.europa.eu
Buyer: Университетска многопрофилна болница за активно лечение по инфекциозни и паразитни болести "Проф. Иван Киров ЕАД | Notice type: cn-standard | P...
TenderProcurement ContractBulgariaOpen
AmountNot provided on the source page. Please check the official source.
DeadlineMar 1, 2029
Buyer: Университетска многопрофилна болница за активно лечение по инфекциозни и паразитни болести "Проф. Иван Киров ЕАД | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2029-03-01
TEN
Finland – Telecommunications services – Tiera puhe + data operaattorikilpailutus hyvinvointialueille ja muille asiakkaille - DPS 2022
Research Grants in Clinical Informatics (R01 Clinical Trial Optional)
grants.gov
The National Library of Medicine (NLM) seeks applications for innovative research in clinical informatics. The overarching goal of this forthcoming pr...
GrantCash GrantUnited StatesOpen
AmountAward range: $0 - $250,000
DeadlineMar 5, 2029
The National Library of Medicine (NLM) seeks applications for innovative research in clinical informatics. The overarching goal of this forthcoming program is to catalyze the development and advancement of novel informatics methodologies that empower clinicians, patients, and the broader public to better understand, manage, and improve health and health care delivery. This NOFO will support research focused on the design, implementation, and evaluation of clinical informatics tools and methods that enable data-driven discovery, promote evidence-based decision-making, and support personalized and precision health care. Emphasis will be placed on domain-independent, scalable, and reusable/reproducible approaches for the discovery, analysis, organization, and management of health-related digital objects—including electronic health records (EHRs), clinical notes, imaging data, and patient-generated data. The aim is to transform raw and heterogeneous health data into actionable knowledge, t...
GRA
Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)
grants.gov
The National Library of Medicine (NLM) seeks applications for research projects that drive groundbreaking innovation and advanced development in the f...
GrantCash GrantUnited StatesOpen
AmountAward ceiling: $250,000
DeadlineMar 5, 2029
The National Library of Medicine (NLM) seeks applications for research projects that drive groundbreaking innovation and advanced development in the fields of bioinformatics, translational bioinformatics, and computational biology. The primary goal of this initiative is to support the creation and implementation of cutting-edge methods, tools, and approaches that can transform the landscape of biomedical data science. This NOFO aims to address the growing need to leverage transformative technologies — such as artificial intelligence (AI), machine learning, and large-scale computational platforms — to extract actionable knowledge from vast, diverse, and complex biological datasets. By enabling more effective interpretation and integration of multi-dimensional biological and biomedical data, this research will ultimately contribute to improving individual and population health outcomes.
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Nintedanib (VARGATEF und Generika), ATC L01EX09 für die Zeit 01.05.26-30.04.28 (zzgl. V.-Option 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Estradiol (ausschl. DaFo SPT), ATC G03CA03 für die Zeit 01.05.26 - 30.04.28 (zzgl. V.-Option 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Chlortalidon, ATC C03BA04 für die Zeit 01.05.26-30.04.28 (zzgl. V.-Option 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Estradiol (ausschl. DaFo UTA/TAB), ATC G03CA03 für die Zeit 01.05.26-30.04.28 (zzgl.V.-Option 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Glyceroltrinitrat, ATC C05AE01 für die Zeit 01.05.26 - 30.04.28 (zzgl. V.-Option 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Nintedanib (OFEV und Generika), ATC L01EX09 für die Zeit 01.05.26-30.04.28 (zzgl. V.-Option 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Ciclopirox, ATC D01AE14 für die Zeit 01.05.26 - 30.04.28 (zzgl. V.-Option 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Megestrol, ATC L02AB01 für die Zeit 01.05.26 - 30.04.28 (zzgl. V.-Option 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Lapatinib, ATC L01EH01 für die Zeit 01.05.26-30.04.28 (zzgl. V.-Option 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Testosteron (ausschl. DaFo GEL), ATC G03BA03 für die Zeit 01.05.26 - 30.04.28 (zzgl. V.-Option 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Estradiol (ausschl. DaFo GEL), ATC G03CA03 für die Zeit 01.05.26 - 30.04.28 (zzgl. V.-Option 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Pimecrolimus, ATC D11AH02 für die Zeit 01.05.26 - 30.04.28 (zzgl. V.-Option 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Clindamycin (ausschl. DaFo VSU), ATC G01AA10 für die Zeit 01.05.26 - 30.04.28 (zzgl. V.-Option 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Moxifloxacin, ATC S01AE07 für die Zeit 01.05.26 - 30.04.28 (zzgl. V.-Option 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Diltiazem, ATC C08DB01 für die Zeit 01.05.26 - 30.04.28 (zzgl. V.-Option 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Dydrogesteron + Estrogen, ATC G03FB08 für die Zeit 01.05.26 - 30.04.28 (zzgl. V.-Option 1x12 Monate)
Use the star icon near an opportunity title to add it to Favorites.
📅 Best viewed on desktop - or rotate your phone to landscape mode.
#
Opportunity
Type
Region / Country
Amount
Deadline
Source
41676
Finland – Social work and related services – Lasten ja perheiden palvelutBuyer: Pohjois-Pohjanmaan hyvinvointialue | Notice type: cn-social | Procedure: restricted | Contract: services | Deadline: 2029-0...
Tender
Procurement Contract
Finland
Not provided on the source page. Please check the official source.
Sweden – Health and social work services – DIS bemanningstjänster sjuksköterskor, fysioterapeuter och arbetsterapeuterBuyer: Uddevalla kommun | Notice type: cn-social | Procedure: oth-mult | Contract: services | Deadline: 2029-02-28
Tender
Procurement Contract
Sweden
Not provided on the source page. Please check the official source.
Bulgaria – Medical consumables – ДОСТАВКА НА МЕДИЦИНСКИ ИЗДЕЛИЯ, ПРЕВЪРЗОЧНИ МАТЕРИАЛИ и ПАМПЕРСИ за УМБАЛИПБ ''ПРОФ. ИВАН КИРОВ"Buyer: Университетска многопрофилна болница за активно лечение по инфекциозни и паразитни болести "Проф. Иван Киров ЕАД | Notice t...
Tender
Procurement Contract
Bulgaria
Not provided on the source page. Please check the official source.
Buyer: Университетска многопрофилна болница за активно лечение по инфекциозни и паразитни болести "Проф. Иван Киров ЕАД | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2029-03-01
41679
Finland – Telecommunications services – Tiera puhe + data operaattorikilpailutus hyvinvointialueille ja muille asiakkaille - DPS 2022Buyer: Yhteishankintayksikkö Velora Oy | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2029-03...
Tender
Procurement Contract
Finland
Not provided on the source page. Please check the official source.
Research Grants in Clinical Informatics (R01 Clinical Trial Optional)The National Library of Medicine (NLM) seeks applications for innovative research in clinical informatics. The overarching goal of...
The National Library of Medicine (NLM) seeks applications for innovative research in clinical informatics. The overarching goal of this forthcoming program is to catalyze the development and advancement of novel informatics methodologies that empower clinicians, patients, and the broader public to better understand, manage, and improve health and health care delivery. This NOFO will support research focused on the design, implementation, and evaluation of clinical informatics tools and methods that enable data-driven discovery, promote evidence-based decision-making, and support personalized and precision health care. Emphasis will be placed on domain-independent, scalable, and reusable/reproducible approaches for the discovery, analysis, organization, and management of health-related digital objects—including electronic health records (EHRs), clinical notes, imaging data, and patient-generated data. The aim is to transform raw and heterogeneous health data into actionable knowledge, to develop innovative tools, and to implement practical applications that can be generalized across multiple clinical settings and populations. Projects should demonstrate the potential to accelerate scientific insights, improve clinical workflows, and ultimately lead to improved health outcomes.
41681
Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)The National Library of Medicine (NLM) seeks applications for research projects that drive groundbreaking innovation and advanced...
The National Library of Medicine (NLM) seeks applications for research projects that drive groundbreaking innovation and advanced development in the fields of bioinformatics, translational bioinformatics, and computational biology. The primary goal of this initiative is to support the creation and implementation of cutting-edge methods, tools, and approaches that can transform the landscape of biomedical data science. This NOFO aims to address the growing need to leverage transformative technologies — such as artificial intelligence (AI), machine learning, and large-scale computational platforms — to extract actionable knowledge from vast, diverse, and complex biological datasets. By enabling more effective interpretation and integration of multi-dimensional biological and biomedical data, this research will ultimately contribute to improving individual and population health outcomes.
41682
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Nintedanib (VARGATEF und Generika), ATC L01EX09 für die Zeit 01.05.26-30.04.28 (zzgl. V.-Option 1x12 Monate)Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2029-03-05
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
